T82.868A Insurance Policy Changes

ICD-10 T82.868A is officially defined as "Thrombosis due to vascular prosthetic devices, implants and grafts, initial encounter." code T82.868A is referenced in 3 tracked payer policy changes from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code T82.868A is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Aetna · Identified Oct 5, 2026Medium impact
Thrombectomy Systems (CPB 0568, reviewed 2026-09-18)
Aetna considers the AngioJet Rheolytic Thrombectomy System medically necessary for removing fresh blood clots from arterio-venous fistulas used for hemodialysis, from coronary arteries or coronary bypass grafts that are at least 2.0 mm in diameter before angioplasty or stent placement, and from infra-inguinal peripheral arteries at least 2.0 mm in diameter. It also considers the system medically necessary for individuals with lower extremity deep vein thrombosis who have failed pharmacologic thrombolysis or in whom pharmacologic thrombolysis is contraindicated. Aetna considers the AngioJet system experimental, investigational or unproven for acute aortic occlusion, acute renal artery thrombosis, cerebral venous sinus thrombosis, inferior vena cava filter-related thrombosis, May-Thurner syndrome-related deep venous thrombosis, pulmonary embolism, and thrombosis of the native aortic valve and of the left ventricular assist device in individuals with heart failure. Aetna also considers the ClotHunter system for lower extremity deep vein thrombosis, and mechanical thrombectomy and/or thrombo-aspiration for acute ilio-femoral deep vein thrombosis, experimental, investigational or unproven.
Aetna · Identified Oct 1, 2026Medium impact
Balloon-Expandable Venous Stents (CPB 0531, reviewed 2026-08-27)
Aetna considers placement of balloon-expandable venous stents, with or without initial thrombolysis or surgical thrombectomy, medically necessary for Budd-Chiari syndrome, chronic iliac vein occlusions, chronic ilio-caval vein obstruction, ilio-femoral thrombosis secondary to iliac compression syndrome, ilio-femoral venous obstructive disease, post-operative venous narrowing after repair of sinus venosus atrial septal defect, salvage of thrombosed or stenotic arterio-venous dialysis access grafts, superior or inferior vena caval stenosis in a child or adult, symptomatic pelvic venous spurs (May-Thurner syndrome), and venous obstruction of the superior or inferior limb of an atrial baffle after Mustard or Senning repair. Venous stenting is also medically necessary for superior vena cava occlusive disease. Balloon-expandable venous stents are experimental, investigational, or unproven for all other indications, including management of central vein stenosis in hemodialysis individuals and porto-mesenteric and porto-systemic venous reconstruction.
Aetna · Identified Aug 18, 2026Medium impact
Thrombectomy Systems (CPB 0568, reviewed 2025-08-26)
Aetna considers the AngioJet Rheolytic Thrombectomy System medically necessary for removing fresh blood clots from arteriovenous fistulas used for hemodialysis, from coronary arteries or coronary bypass grafts at least 2.0 mm in diameter before angioplasty or stent placement, from infra-inguinal peripheral arteries at least 2.0 mm in diameter, and in individuals with lower extremity deep vein thrombosis who have failed pharmacologic thrombolysis or in whom pharmacologic thrombolysis is contraindicated. Thrombectomy systems are considered experimental, investigational or unproven for acute aortic occlusion, acute renal artery thrombosis, cerebral venous sinus thrombosis, inferior vena cava filter-related thrombosis, May-Thurner syndrome-related deep venous thrombosis, pulmonary embolism, and thrombosis of the native aortic valve and of the left ventricular assist device in heart failure. The ClotHunter for lower extremity deep vein thrombosis and mechanical thrombectomy or thrombo-aspiration for acute ilio-femoral deep vein thrombosis are also considered experimental, investigational or unproven.

Watch T82.868A

Get one email when a payer policy names T82.868A, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

FREQUENTLY ASKED QUESTIONS

What insurance policy changes affect code T82.868A?

There are 3 tracked policy changes affecting code T82.868A, including updates from Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code T82.868A?

Payers that have issued tracked updates for code T82.868A include: Aetna.

How do I get notified when code T82.868A policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code T82.868A. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code T82.868A?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Thrombectomy Systems (CPB 0568, reviewed 2026-09-18)

Balloon-Expandable Venous Stents (CPB 0531, reviewed 2026-08-27)

Thrombectomy Systems (CPB 0568, reviewed 2025-08-26)

What insurance policy changes affect code T82.868A?

Which payers have updated policy for code T82.868A?

How do I get notified when code T82.868A policy changes?

Why do payers change policies for code T82.868A?